Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos KL Stenvers, ML Tursky, KW Harder, N Kountouri, S Amatayakul-Chantler, ... Molecular and Cellular Biology 23 (12), 4371-4385, 2003 | 303 | 2003 |
Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes A Unnikrishnan, E Papaemmanuil, D Beck, NP Deshpande, A Verma, ... Cell reports 20 (3), 572-585, 2017 | 125 | 2017 |
Ex vivo expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS‐5 stromal cell line A Tiwari, ML Tursky, D Mushahary, S Wasnik, FM Collier, K Suma, ... Journal of Tissue Engineering and Regenerative Medicine 7 (11), 871-883, doi …, 2013 | 51 | 2013 |
miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia TT Vu, F Stölzel, KW Wang, C Röllig, ML Tursky, TJ Molloy, DD Ma Leukemia 35 (7), 1933-1948, 2021 | 35 | 2021 |
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias ML Tursky, D Beck, JA Thoms, Y Huang, A Kumari, A Unnikrishnan, ... Leukemia 29 (4), 819-27, doi: 10.1038/leu.2014.299, 2015 | 28 | 2015 |
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation Y Huang, JA Thoms, ML Tursky, K Knezevic, D Beck, V Chandrakanthan, ... Leukemia, 2016 | 27 | 2016 |
Expansion of Human Hematopoietic Stem/Progenitor Cells on Decellularized Matrix Scaffolds A Tiwari, ML Tursky, LP Nekkanti, G Jenkin, MA Kirkland, G Pande Current Protocols in Stem Cell Biology 36, 1C.15.1-16, 2016 | 26 | 2016 |
Systematic investigation of oxygen and growth factors in clinically valid ex vivo expansion of cord blood CD34+ hematopoietic progenitor cells ML Tursky, FM Collier, AC Ward, MA Kirkland Cytotherapy 14 (6), 679-685, 2012 | 23 | 2012 |
Direct comparison of four hematopoietic differentiation methods from human induced pluripotent stem cells ML Tursky, TH Loi, CM Artuz, S Alateeq, EJ Wolvetang, H Tao, DD Ma, ... Stem Cell Reports 15 (3), 735-748, 2020 | 22 | 2020 |
Do phytogeographic patterns reveal biomes or biotic regions? DJ Murphy, MC Ebach, JT Miller, SW Laffan, G Cassis, V Ung, ... Cladistics 35 (6), 654-670, 2019 | 20 | 2019 |
On Classification and Taxonomy of Coronaviruses (Riboviria, Nidovirales, Coronaviridae) with special focus on severe acute respiratory syndrome-related coronavirus 2 (SARS-Cov-2) EV Mavrodiev, ML Tursky, NE Mavrodiev, MC Ebach, DM Williams bioRxiv, 2020.10. 17.343749, 2020 | 15 | 2020 |
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia E Moles, CB Howard, P Huda, M Karsa, H McCalmont, K Kimpton, A Duly, ... Science Translational Medicine 15 (696), eabm1262, 2023 | 10 | 2023 |
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine A Yeola, S Subramanian, RA Oliver, CA Lucas, JAI Thoms, F Yan, ... Science Advances 7 (3), eabd1929, 2021 | 5 | 2021 |
Defective heart and liver development in type III TGFbeta-receptor-deficient embryos KL Stenvers, N Kountouri, M Tursky, S Amatayakul-Chantler Annu. Meet. Soc. Dev. Biol., 61st., Madison, WI, 2002 | 2 | 2002 |
Topic: AS02-Epidemiology: CHIP AND INCIDENTAL ANAEMIA IN PATIENTS REFERRED TO SYDNEY GERIATRIC CLINICS FOR FRAILTY ASSESSMENT–A PROSPECTIVE STUDY D Ma, T Malloy, C Artuz, M Tursky, F Tran, P Reyes Leukemia Research 128, 107159, 2023 | | 2023 |
3133–DIRECT COMPARISON OF IMPROVED METHOD FOR HUMAN INDUCED PLURIPOTENT STEM CELL (IPSC) HAEMATOPOIETIC DIFFERENTIATION SHOWS ENHANCED EFFICIENCY AND SENSITIVITY AT REDUCED COST M Tursky, S Alateeq, C Artuz, TH Loi, D Ma, T Molloy, H Tao, E Wolvetang Experimental Hematology 100, S107, 2021 | | 2021 |
3101–MIR-10A AS A THERAPEUTIC TARGET AND PREDICTIVE BIOMARKER FOR MDM2 INHIBITION IN ACUTE MYELOID LEUKEMIA T Molloy, D Ma, C Röllig, F Stölzel, M Tursky, TT Vu, K Wang Experimental Hematology 100, S91, 2021 | | 2021 |
Method for the ex vivo expansion of hematopoietic stem and progenitor cells ML Tursky, MA Kirkland US Patent 9,518,250, 2016 | | 2016 |
INTEGRATIVE GENOMICS IDENTIFIES THE MOLECULAR BASIS OF RESISTANCE TO AZACITIDINE THERAPY IN MYELODYSPLASTIC SYNDROMES A Unnikrishnan, E Papaemmanuil, D Beck, A Verma, A Kumari, P Woll, ... HAEMATOLOGICA 101, 157-158, 2016 | | 2016 |
An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML A Unnikrishnan, E Papaemmanuil, D Beck, A Verma, A Kumari, ... Blood, The Journal of the American Society of Hematology 126 (23), 710-710, 2015 | | 2015 |